相关实验视频

Updated: May 17, 2025

A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure

A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure

Published on: April 30, 2020

在高血压引起的心脏重塑中,形态度和分子相互作用,重点是潜在的治疗影响

Lyubomir Gaydarski¹, Kristina Petrova¹, Stancho Stanchev¹

¹Department of Anatomy, Histology and Embryology, Medical University of Sofia, 1431 Sofia, Bulgaria.

International journal of molecular sciences

|May 14, 2025

概括

高血压通过改变血管并导致纤维化而损害心脏. 准诸如阿比利内尔基和氧化等途径可能为高血压心脏病提供新的治疗方法.

科学领域:

心血管生物学心血管生物学
分子医学是分子医学.
病理生理学病理生理学

背景情况:

高血压诱导心脏重塑,导致心室缩,纤维化,血管生成受损和功能障碍.
关键的分子和细胞机制驱动这些变化,影响心肌结构和功能.

研究的目的:

审查高血压心肌中的体形变化,重点关注毛细血管密度,纤维化和巨细胞.
探索 apelinergic 系统,VEGF/VEGFR 和 NO/NOS 信号在高血压心脏病 (HHD) 中的作用.

主要方法:

检查毛细血管密度,纤维化和巨细胞的组织形态变化.
监管系统的分析,包括 apelinergic,VEGF/VEGFR 和 NO/NOS 信号通路.
讨论HHD的治疗目标和干预措施.

主要成果:

毛细血管稀缺是HD的标志,有助于缺血和纤维化.
心肌纤维化涉及原沉积,受FGF-2和TGF-β的影响.
由于其血管扩张和抗纤维性质,阿皮内尔基系统显示出有希望的结果.
VEGF信号传递有双重作用,NO/NOS通路的失调导致内皮功能障碍.

结论:

向毛细血管密度和纤维化有可能改善HHD的心脏结果.
apelinergic 系统是一个有希望的治疗途径,尽管人类研究是有限的.
恢复NO生物可用性和仔细调节VEGF信号是潜在的策略.
个性化HHD治疗需要一个多学科的方法.

关键词:

这就是阿佩林 (apelin) 的意思.阿佩林受体的受体是什么毛细血管的密度密度纤维化纤维化高血压的心肌肌肉.巨细胞巨细胞氧化合成酶是一种氧化合成酶.治疗意义的治疗影响.血管内皮生长因子血管内皮生长因子

更多相关视频

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents

Published on: July 14, 2021

相关概念视频

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Pathophysiology of Heart Failure

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...

Hypertension and Regulation of Blood Pressure

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...